Kapadia Sandip
CHIEF FINANCIAL OFFICER
Kapadia Sandip has filed 6 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jan 28, 2026.
On the most recent filing, Kapadia Sandip is listed as CHIEF FINANCIAL OFFICER at Harmony Biosciences Holdings, Inc. Inside the rolling window, Kapadia Sandip reported no open-market purchases and 4 open-market sales totaling $1.8M in HRMY. The largest disclosed transaction in the window is a sale of 20,000 HRMY shares on Dec 5, 2025, worth $791K.
Companies traded
Other insiders at HRMY
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.8M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kapadia Sandip made?
Kapadia Sandip has filed 6 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does Kapadia Sandip trade?
Kapadia Sandip has filed SEC Form 4 disclosures for 1 company, including HRMY.
When was Kapadia Sandip's most recent SEC Form 4 filing?
Kapadia Sandip's most recent SEC Form 4 filing on Tracefour is dated Jan 28, 2026.
What is Kapadia Sandip's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kapadia Sandip is listed as CHIEF FINANCIAL OFFICER.
What is Kapadia Sandip's total buy and sell value in the current window?
Inside the rolling retention window, Kapadia Sandip bought $0 and sold $1.8M based on SEC Form 4 filings.
What was Kapadia Sandip's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 20,000 HRMY shares on 2025-12-05, worth $791K, per SEC Form 4 filings.